非ST段抬高急性冠状动脉综合征(non-ST-segment elevation acute coronary syndromes,NSTEACS)已成患者急诊和入院的主要原因,其抗血小板、抗凝、调脂、介入治疗等方面研究对提高患者的生存率及生存质量有重要意义。近年来,关于新的治疗药物、治疗方法的选择、介入治疗的时机及特殊人群的处理等方面都有一些新的进展。 Non-ST-segment elevation acute coronary syndromes (NSTEACS) have become the major cause of emergency and admission of patients, and their anti-platelet, anticoagulation, lipid-lowering, interventional therapy and other aspects of research to improve Patient’s survival rate and quality of life are of great significance. In recent years, there has been some new progress on new therapeutic drugs, the choice of treatment methods, the timing of interventional therapy and the treatment of special populations.